Allogene Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Allogene Therapeutics, Inc.
1.12
+0.03 · +2.57%
−4.35%
vs ±13.3% implied · ×0.33
shaded = implied · ▲▼ = realized
Linked news
209 managers report $652.8M of Allogene Therapeutics on form 13F for the quarter ended Jun 30 '26. 26 of them hold 80% of it; BlackRock is largest at 9.61%.
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $62.7M | 9.61% | +57.91% | |
| 2 | PfizerPfizer | $46.9M | 7.19% | 0.00% | |
| 3 | Frazier Life Sciences ManagementFrazier Life Sciences | $46.7M | 7.15% | +491.22% | |
| 4 | State StreetState Streetindex-like | $39.6M | 6.06% | +119.69% | |
| 5 | TPG GP ATPG GP A | $38.9M | 5.96% | 0.00% | |
| 6 | Sio Capital ManagementSio | $27.7M | 4.25% | new | |
| 7 | Primecap ManagementPrimecap | $27.3M | 4.18% | +56.61% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $25.3M | 3.88% | +75.78% | |
| 9 | FMRFMR | $25.0M | 3.83% | +655.37% | |
| 10 | Citadel AdvisorsCitadel | $21.3M | 3.26% | +48.44% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $16.2M | 2.48% | +44.81% | |
| 12 | Geode Capital ManagementGeodeindex-like | $14.7M | 2.25% | +70.93% | |
| 13 | Goldman Sachs GroupGoldman Sachs | $12.8M | 1.96% | +122.29% | |
| 14 | GordonMD Global InvestmentsGordonMD Global | $11.0M | 1.69% | +270.49% | |
| 15 | Marshall WaceMarshall Wace | $10.6M | 1.62% | +47.78% | |
| 16 | Patient Square CapitalPatient Square Capital | $10.5M | 1.61% | +46.38% | |
| 17 | Standard Life AberdeenStandard Life Aberdeen | $10.4M | 1.59% | +242.07% | |
| 18 | Millennium ManagementMillennium | $10.1M | 1.54% | +45.81% | |
| 19 | D. E. ShawD. E. Shaw | $9.8M | 1.50% | +70.45% | |
| 20 | T. Rowe Price AssociatesT. Rowe Price | $9.7M | 1.48% | −13.78% | |
| 21 | Morgan StanleyMorgan Stanley | $9.4M | 1.44% | +351.52% | |
| 22 | Woodline PartnersWoodline Partners | $9.4M | 1.43% | +28.55% | |
| 23 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $9.0M | 1.38% | +44.67% | |
| 24 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $8.8M | 1.34% | +148.63% | |
| 25 | Renaissance TechnologiesRenaissance Technologies | $8.0M | 1.22% | +79.23% |
Fund move
No thesis.
Expected move
Inputs8Q avg ±6.5%·×1.93·rich
straddle ±23.4%
spot 1.09exp Nov 20ATM strike 1ATM straddle 0.30IV 158%